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Abstract 
Streptococcus (S.) suis is a globally important swine pathogen, which comprises certain zoonotic serotypes. In this 
study, a detailed characterization of 88 porcine S. suis isolates was performed by analyzing capsular (cps) types, 
multilocus sequence typing (MLST) and investigation of the minimum core genome (MCG). In order to focus on the 
virulence potential of presumable invasive disease-associated S. suis isolates, virulence-associated gene profiles were 
assessed followed by screening a chosen subset of S. suis strains with a molecular pathotyping tool. Results showed a 
high genetic variability within this strain collection. In total, seventeen cps types were identified with a predominance 
of cps type 9 (15.9%) and 6 (14.8%). MLST revealed 48 sequence types (STs) including 41 novel ones. The popula-
tion structure of S. suis was heterogenous and isolates belonged to eight different clonal complexes (CCs) including 
CC28 (9.1%), CC1109 (8%), CC13/149 (6.8%), CC1237 (5.7%), CC1 (3.4%), CC17 (3.4%), CC87 (2.3%), and CC1112 (1.1%), 
whereas a significant portion of isolates (60.2%) could not be assigned to any described CCs. Virulence-associated 
markers, namely extracellular protein factor (epf), muramidase-released protein (mrp), and suilysin (sly), showed a 
link with STs rather than with cps types. With this study an expanded knowledge about the population structure and 
the genetic diversity of S. suis could be achieved, which helps to contribute to an optimal public health surveillance 
system by promoting a focus on strains with an increased virulence and zoonotic potential.
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Introduction
Streptococcus suis (S. suis) is a Gram-positive bacterium 
recognized to be an important swine pathogen responsi-
ble for various diseases including septicemia with sudden 
death, meningitis, endocarditits, polyserositis, and arthri-
tis [1]. S. suis also colonizes the upper respiratory tract 
with commensal strains giving rise to carrier pigs [2]. 
Moreover, S. suis can appear as an opportunistic patho-
gen in combination with other pathogens [3]. In addition, 
infection with S. suis not only leads to major economic 
problems due to important losses in pig production 
worldwide, but the bacterium is also capable of infect-
ing humans. In Western countries, infection of humans 
usually involves a single person such as pig farmers, 
veterinarians, people who work at abattoir, or butchers. 
Infection mainly takes place through direct contact of 
skin wounds with contaminated pork even in cases where 
no obvious wound is present [4]. On the other hand, in 
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Southeast Asian countries, the main route of infection 
seems to be the gastrointestinal tract where consumption 
of undercooked pork products or a traditional soup con-
taining raw pig blood is common and humans frequently 
live in close contact to pigs [5]. The most frequently 
described manifestations in humans are meningitis and 
septic shock [6].
Currently, there are at least 29 S. suis serotypes [7] 
described based on a serological reaction against the cap-
sular polysaccharide, which has been commonly reported 
to be a major virulence factor with antiphagocytic prop-
erties [8]. Strains of heterogeneous serotype 2, which are 
responsible for more than 80% of human cases, repre-
sent a globally emerging zoonotic threat [9]. To a lesser 
extent, serotype 14 is also associated with disease in both 
humans and pigs [10]. Worldwide, major S. suis serotypes 
isolated from diseased pigs are serotypes 2, 9, 3, 1/2 and 
7 [9]. In some European countries, serotype 9 strains are 
emerging and are considered to be responsible for caus-
ing disease among pigs [11] and sporadically capable to 
infect humans as reported in one case report from Thai-
land [12].
The most commonly described virulence markers for 
S. suis include muramidase-released protein (MRP) [13], 
extracellular protein factor (EF) [14], and the hemolysin 
suilysin (SLY) [15], which were mainly associated with a 
virulence potential of S. suis serotype 2 strains [16]. MRP 
is a surface protein anchored to the cell wall [17] and has 
recently been shown to be a major fibrinogen-binding 
protein [18]. Human fibrinogen bound to MRP increases 
viability of S. suis serotype 2 in human blood and its capa-
bility of migrating across the human cerebral endothe-
lial cell barrier, thereby promoting the development of 
meningitis [19]. EF is secreted independent of an inter-
action between bacteria and host cell involved in enhanc-
ing bacterial infection, invasion, and pathogenicity [20]. 
Both MRP and EF have variants of different molecular 
weights [21, 22]. Strains harboring the short form of epf 
are considered the most virulent form of the epf subtypes 
[21]. SLY is a thiol-activated toxin antigenically related to 
cholesterol-binding toxins, which forms transmembrane 
pores [23] and is described to be toxic to phagocytic, 
endothelial, and epithelial cells [24]. However, since iso-
genic mutants can be found, which do not express MRP, 
EFP, and/or SLY and are still virulent, it is more precise to 
term those factors as virulence-associated markers [14].
Multilocus sequence typing (MLST) is a useful method 
to examine the population structure and provide epide-
miological tracing of pathogenic bacteria. It has been 
applied to various species and is a valuable tool that 
allows further investigation of the global distribution 
and evolution of several pathogens [25], including S. suis 
as reported in former studies [26, 27]. The classification 
of sequence types (STs) resulting from MLST allows 
grouping of genetically similar genotypes in clonal com-
plexes (CCs), thus revealing the population structure of 
S. suis. Various CCs are identified globally, whereas the 
prevalence of certain genotypes can vary in different geo-
graphical regions. The most important CCs implicated in 
human infections are the following: CC1 (harboring most 
important ST1) in Europe, Asia, North- and South Amer-
ica, and Africa [28]; CC20 in the Netherlands [11]; CC25 
and CC28 in North America, Australia, and Asia [28], 
although in the United States an increasing trend of the 
genetically diverse CC94 was observed [29]. In Europe, a 
high prevalence of virulent mrp + epf + sly + cps2 strains 
being part of CC1 and mrp*cps9 strains of CC16/87 can 
be noticed [30].
A molecular surveillance tool to predict the virulence 
potential of S. suis, by differentiating potentially invasive 
disease-associated strains from commensal or possibly 
opportunistic non-disease-associated strains is of advan-
tage. Such a pathotyping tool was recently described by 
Wileman et  al. [31] and, provided that its application is 
successful, could be used as a convenient and promising 
diagnostic assay enabling the detection of highly virulent 
emerging strains. Based on whole genome sequencing 
data, three pathotyping markers were identified [31]. First 
of all, a disease-associated marker was described, which 
is predicted to be a copper-exporting ATPase (SSU207) 
potentially playing an essential role in copper homeosta-
sis in Gram-positive and -negative bacterial pathogens 
[31, 32]. The second proposed disease-associated marker 
is annotated as type I restriction-modification (RM) 
system S protein (SSU1589) in S. suis strain P1/7 (Gen-
Bank accession number NC_012925.1) and is supposed 
to be implicated in the defense of host bacteria [33]. The 
third genetic marker is thought to be non-disease-asso-
ciated and the corresponding protein is suggested to be 
a putative sugar ATP-binding cassette (ABC) transporter 
(SSUST30534).
The aim of this study was to determine the genetic 
diversity of Swiss porcine S. suis isolates collected during 
the past 13 years and to assess their virulence potential. 
Observed phenotypes arising from pathological, histo-
logical and bacteriological examinations were compared 
to the virulence-associated genotype profiles obtained 
by analyzing the classical virulence-associated markers 
(mrp, efp and sly) and by classifying the S. suis popula-
tion using a system based on minimum core genome 
(MCG). Moreover, a selected subset of S. suis strains, 
based on a comprehensive data availability of histopatho-
logical findings of the corresponding clinical cases, was 
screened with an available novel pathotyping tool [31]. 
The identification of major pathogenic strains could help 
to establish an optimal public health surveillance system 
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by promoting a focus on strains with an increased viru-
lence and zoonotic potential.
Materials and methods
Streptococcus suis isolates
In this study a total of 88 porcine isolates obtained from 
routine diagnostic submissions to the Department of 
Veterinary Bacteriology at the Vetsuisse Faculty, Univer-
sity of Zurich, within the time span of 2006–2019, were 
included. The samples were recovered from 77 inde-
pendent farms located in three main regions of Switzer-
land (Central- and Eastern part, and Canton of Zurich) 
with one to three samples per farm always derived from 
different animals. No isolates came from the French 
speaking Western part of Switzerland and the Canton 
of Bern. Isolates of the same farm were included only if 
STs were different. Samples analyzed originated from 
the following sites: 34.1% (n = 30/88) from blood, 20.5% 
(n = 18/88) from brain, 14.8% (n = 13/88) from lung, 
11.4% (n = 10/88) from joint, 8% (n = 7/88) from heart, 
3.4% (n = 3/88) from genital tract, 2.3% (n = 2/88) each 
from abscess and kidney, and 1.1% (n = 1/88) each from 
abdominal cavity, nasal swab and liver (Table 1). In order 
to verify the relevance of the S. suis isolates, the results 
of the histological examination were consulted. S. suis 
infection was considered as relevant in cases where the 
histological diagnoses included meningitis, polyarthri-
tis, endocarditis, or placentitis, and when histological 
features consistent with septicemia [34] were observed. 
In two cases no histopathology was performed, but S. 
suis was determined relevant due to clear bacteriologi-
cal findings (pure culture of S. suis), appropriate anam-
nesis and clinical signs. Isolates, for which a clear link 
to S. suis could be ruled out histopathologically (due to 
inappropriate age or due to another etiological diag-
nosis), were termed as not relevant. Isolates with an 
incomplete record of data, no S. suis relevance could be 
assigned and were therefore excluded for screening with 
the pathotyping tool.
DNA extraction and species identification
Isolates were cultured for 24 to 48 h at 37 °C on Columbia 
blood sheep agar plates (Thermo Fisher Diagnostics AG, 
Pratteln, Switzerland) under aerobic conditions. DNA 
was extracted using a standard heat lysis protocol [35]. 
Briefly, colony material was dissolved in lysis buffer con-
taining Proteinase K at 60 °C for 45 min under constant 
shaking followed by a heat deactivation step at 96 °C for 
15 min. DNA samples were diluted to 20 ng/µl for subse-
quent reactions.
The isolates were identified by matrix-assisted laser 
desorption ionization-time-of-flight mass spectrometry 
(MALDI-TOF MS, Bruker, Bremen, Germany). In addi-
tion, to confirm S. suis species, a recN (recombination/
repair protein gene) PCR was performed as described 
earlier [36].
Capsular typing and MLST
Capsular typing was performed as previously described 
[37]. Universal primers targeting 16S rRNA gene were 
used for internal control of the PCR reactions [38]. PCR 
products were analyzed on a capillary electrophoresis 
QIAxcel Advanced device (Qiagen, Hilden, Germany) 
using a screening cartridge, QX 15  bp–3  kb alignment 
marker and QX 100  bp–2.5  kb size marker (Qiagen) 
according to the manufacturer’s instructions. The result-
ing electropherograms were viewed with the QIAxcel 
ScreenGel 1.2.0 software (Qiagen). Isolates with capsular 
(cps) type pair 2 or 1/2 and 1 or 14 were assigned to the 
corresponding cps type using a recently developed HRM 
assay [39].
MLST was performed targeting aroA, cpn60, dpr, gki, 
recA, thrA and mutS as described previously [26]. For 
strains with no PCR amplification using primer mutS, 
alternative mutS primers have been used as described 
[40]. Briefly, PCR was set up in a final volume of reac-
tion mixture of 20 µl containing HotStartTaq Master Mix 
(Qiagen), 0.5 µM of each primer pair and 20 ng template 
DNA with cycling conditions as described [26]. Sequenc-
ing of the seven housekeeping genes was performed by 
Sanger sequencing (Microsynth, Balgach, Switzerland). 
CLC Main Workbench 7.0.1 was used for sequence 
analysis. STs were assigned based on PubMLST data-
base (https ://pubml st.org/ssuis ). New housekeeping gene 
alleles were submitted to the database in order to create 
new STs. For visualizing groups of related genotypes and 
for identification of CCs, Swiss isolates were clustered at 
Table 1 Number of porcine S. suis isolates from 
corresponding site of isolation. 
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triple locus variant level with all isolates from the S. suis 
database (2289 isolates on September 27, 2019). The goe-
BURST algorithm from Phyloviz software [41] was used 
to visualize CCs and to create a MLST-based minimal 
spanning tree. CCs comprised STs with at least six identi-
cal alleles. STs that did not form any group were defined 
as singletons and unrelated STs grouping only with indi-
vidual STs were indicated as non-defined founders.
Virulence‑associated gene profiling and MCG typing
All S. suis isolates were tested for three virulence-associ-
ated genes (mrp, epf, sly) by multiplex PCR using primers 
as described previously [22]. Additionally, a epf monoplex 
PCR [22] was conducted to ensure reliable detection of 
large variants of the epf gene designated as epf* [21]. To 
accurately differentiate size variants of mrp, a PCR was 
performed using the mrp variant primers as described 
previously [22]. The PCR assays were performed using 
HotStartTaq Master Mix (Qiagen) according to the man-
ufacturer’s instructions. MCG sequence typing was per-
formed as described previously [42].
Pathotyping
Pathotyping was carried out using a recently devel-
oped multiplex PCR [31] by analyzing a selected subset 
of 75 isolates, which could be linked without any doubt 
to either etiologically relevant S. suis diseased or not S. 
suis relevant diseased pigs (Table 2). Briefly, a multiplex 
PCR was conducted using primers targeting two disease-
associated genes (copper exporting ATPase 1 and type 
I RM system S protein), one non-disease-associated 
marker (putative sugar ABC transporter), and S. suis 
specific primers (sporulation regulator WhiA). The mul-
tiplex PCR was executed using HotStartTaq Mix (Qia-
gen) applying the three-step thermal cycling program as 
described previously [31]. PCR products were analyzed 
on a capillary electrophoresis QIAxcel Advanced device 
(Qiagen) using a screening cartridge, QX 15  bp–3  kb 
alignment marker and QX 100  bp–2.5  kb size marker 
(Qiagen) according to the manufacturer’s instructions.
Whole genome sequencing of a selected panel of isolates
Whole genome sequencing (WGS) of a selected panel 
comprising 13 Swiss clinical S. suis strains of porcine 
origin has been performed previously [43]. Strains were 
chosen based on the aim to cover isolates of the most 
prevalent cps types (cps6 and cps9) and cps types most 
likely supposed to be virulent (cps1/2, cps1 and cps2) 
taking into consideration different years of sampling. 
Briefly, genomic DNA was isolated with the DNA Blood 
and Tissue Kit (Qiagen) and sequencing was performed 
on a MiniSeq sequencer (Illumina, San Diego, USA) with 
150-bp paired-end reads using the Nextera DNA Flex kit 




In total, 88 isolates were obtained. Detailed histopatho-
logical investigations and bacteriological examinations 
revealed 52 isolates as S. suis relevant and 23 isolates as 
not S. suis relevant. For 13 isolates no detailed records 
were available and therefore, were not included in the 
comparison with the pathotyping tool. The most fre-
quently reported history was found to be occurrence of 
sudden death of one or more pigs on a farm (n = 29/88) 
and observations of neurological symptoms (n = 24/88). 
In terms of post-mortem findings, the most commonly 
identified reason of death found by pathologists was sep-
ticemia (n = 27/75) and meningitis (n = 27/75).
Characterization of S. suis isolates by cps typing and MLST
Cps typing of the isolates identified a distribution of sev-
enteen different cps types comprising 89.8% of isolates, 
whereas in 10.2% of cases no cps type could be assigned 
and were therefore classified as nontypeable (NT) (Addi-
tional file 1). Capsular gene analysis yielded two main cps 
types: 15.9% cps9 (n = 14) and 14.8% cps6 (n = 13). Fur-
thermore, the following cps types were identified: cps1 
(n = 6), cps15 (n = 6), cps16 (n = 6), cps7 (n = 4), cps2 
(n = 4), cps8 (n = 3), cps3 (n = 4), cps1/2 (n = 3), cps12 
(n = 3), cps4 (n = 3), cps31 (n = 3), cps5 (n = 2), cps21 
(n = 2), cps28 (n = 2), cps19 (n = 1), and NT (n = 9). Clini-
cally observed S. suis relevant phenotypes confirmed by 
histopathological analysis was detected for isolates of 
cps1, cps2, cps6, and cps7. In contrast, non-relevant S. 
suis features could explicitly be associated with isolates of 
cps8.
MLST analysis revealed that 22.7% of isolates belonged 
to eight previously identified STs, while 77.3% had a new 
MLST profile encompassing 41 new STs. The predomi-
nant STs were ST1104 (cps6, n = 13/13) comprising 14.8% 
of isolates, followed by 9.1% of ST1105 (cps9, n = 8/14), 
and 6.8% of isolates comprised ST13 (cps1, n = 6/6). The 
newly assigned STs in this study were ST1099–ST1130, 
ST1133, ST1134, ST1237–ST1240, ST1243, and ST1244 
(Additional file  2). Three isolates of cps2 (n = 3/4) were 
an atypical single locus variant (SLV) of ST1 (ST1103), 
whereas one cps2 isolate (n = 1/4) was identified as a rela-
tively common ST28 (Figure  1). The distribution of STs 
in relation to cps type highlights the diversity of S. suis. 
Thirteen of the seventeen cps types identified enclosed 
multiple STs, ranging from two to six different STs per 
cps type. Cps1, cps4, cps6, and cps19 only harbored one 
ST, whereas cps16 showed the greatest variety of six dif-
ferent STs (Figure 1).
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Distribution of STs in relation to year of isolation
Figure 2 illustrates a MLST-based minimal spanning tree 
of all tested isolates within a time span of 2006–2019. 
ST1104 (cps6, n = 13/13) and ST1105 (cps9, n = 8/14) 
were the most prevalent STs identified in respect to the 
temporal distribution recovered during eight and six 
different years, respectively. ST13 (cps1, n = 6/6) was col-
lected in four different years. ST17 (cps4, n = 3/3), ST29 
(cps7, n = 3/4), ST231 (cps9, n = 1/14; cps3, n = 2/4), 
ST1103 (cps2, n = 3/4), and ST1236 (cps9, n = 3/14) origi-
nated from three different years. ST1101 (cps15, n = 2/6) 
and ST1109 (cps8, n = 1/3; cps9, n = 1/14) were found 








epf mrp sly MLST 
Clonal 
Complex 
MCG SSU0577f SSU1589f SSU0207f SSUST3_0534f Pathotpying result 
PP 423  sepcemia relevant 1/2 - mrp*** - 1133 CC28 4 + - +* - disease-associated 
MB 1192 pneumonia not relevant 1/2 - mrpS - 28 CC28 4 + - +* - disease-associated 
MB 1598 meningis relevant 1 - - sly 13 CC13/149 N + - - - non-disease-associated 
PP 269 sepcemia relevant 1  - - sly 13 CC13/149 N + - - - non-disease-associated 
PP 735 polyarthris relevant 1  - - sly 13 CC13/149 N + - - - non-disease-associated 
PP 730 meningis, polyarthris relevant 1 - - sly 13 CC13/149 N + - - - non-disease-associated 
MB 1635 polyarthris, sepcemia relevant 1 - - sly 13 CC13/149 N + - - - non-disease-associated 
MB 1656 meningis, polyarthris relevant 1  - - sly 13 CC13/149 N + - - - non-disease-associated 
MB 1329 meningis relevant 2 - mrp sly 1103 CC1 1 + + + - disease-associated 
MB 1555 * relevant 2 - mrp sly 1103 CC1 1 + + + - disease-associated 
19-1715-1  * relevant 2 epf* mrp sly 1103 CC1 1 + + + - disease-associated 
PP 463 endocardis valvularis relevant 2 - mrpS - 28 CC28 4 + - +* - disease-associated 
PP 784 meningis, polyarthris relevant 3 - - sly 231 CC1109 N + - +* - disease-associated 
MB 1313 meningis relevant 3 - - sly 231 CC1109 N + - +* - disease-associated 
MB 454 sepcemia relevant 3 - - sly 1113 CC1109 N + - +* - disease-associated 
MB 1355 peritonis, polyarthris not relevant 3 - mrp*** - 856 CC28 4 + - +* - disease-associated 
PP 414 meningis relevant 4 epf mrpS sly 17 CC17 1 + - + - disease-associated 
PP 772 pneumonia not relevant 4 epf mrpS sly 17 CC17 1 + - + - disease-associated 
MB 906 meningis, peritonis not relevant 5 - - - 1114 Sc ungroupabled + - - + non-disease-associated 
MB 1158 endocardis valvularis relevant 5 - - - 1124 Sc novel1e + - - - non-disease-associated 
PP 425 meningis relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
MB 1352 meningis relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
PP 386 meningis relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
MB 1050 meningis relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
PP 504 sepcemia relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
PP 745 sepcemia relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
PP 799 sepcemia relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
MB 185 polyarthris relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
SS 1364 sepcemia relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
SS 3896 sepcemia relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
PP 438 meningis, polyarthris relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
PP 693 polyarthris, sepcemia relevant 6 - - - 1104 ndfc ungroupabled + - - - non-disease-associated 
MB 1593 meningis relevant 7 - - sly 1130 CC87 2 + - + + non-disease-associated 
MB 582 meningis relevant 7 - mrp*** - 29 CC28 4 + - +* - disease-associated 
MB 841 meningis, polyarthris relevant 7 - mrp*** - 29 CC28 4 + - +* - disease-associated 
MB 36 sepcemia relevant 7 - mrp*** - 29 CC28 4 + - +* - disease-associated 
PP 478 emaciaon, colibacillosis not relevant 8 - - sly 1109 CC1109 N + - +* - disease-associated 
PP 283 polyarthris not relevant 8 - - sly 1106 CC1109 N + - +* + non-disease-associated 
MB 386 sepcemia not relevant 8 - - sly 87 CC87 2 + - + + non-disease-associated 
PP 789 sepcemia relevant 9 - - sly 1109 CC1109 N + - +* - disease-associated 
MB 1452 meningis relevant 9 - - sly 231 CC1109 N + - +* - disease-associated 
MB 1497 sepcemia not relevant 9 - - sly 1237 CC1237 novel1e + - - - non-disease-associated 
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within two different years. However, the majority of iso-
lates, representing 43.2% of the tested collective, was iso-
lated uniquely in 1 year.
Association between genotype and CCs
STs of all S. suis isolates were assigned to CCs using the 
eBurst illustration (Figure  3). Among the 88 isolates 
analyzed, eight CCs were identified: CC1, CC17, CC28, 
CC87, CC13/149, CC1109, CC1112, and CC1237 com-
prising 3, 3, 8, 2, 6, 7, 1, and 5 isolates, respectively. The 
Table 2 (continued)
PP 421 meningis relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
MB 706 meningis relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
PP 203 meningis relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
PP 417 sepcemia relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
PP 536 sepcemia relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
PP 722 sepcemia relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
PP 742 meningis relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
MB 923 meningis  relevant 9 - - - 1105 Sc 7-3 + - +* - disease-associated 
SS 3878 polyarthris, peritonis not relevant 9 - - - 1236 CC1237 novel1e + - - - non-disease-associated 
PP 186 acute circulaon shock not relevant 12 - - - 1099 Sc ungroupabled + - - - non-disease-associated 




not relevant 15 epf mrp*** sly 1110 Sc N + - - - non-disease-associated 
PP 402 polyarthris, sepcemia not relevant 15 - mrp* sly 1134 Sc 1 + - - + non-disease-associated 
PP 773 meningis not relevant 15 - - sly 1101 Sc 1 + - - - non-disease-associated 
MB 979 placens, pneumonia relevant 15 - - sly 1115 Sc 1 + - - + non-disease-associated 
PP 429 dermas not relevant 16 - - - 1107 ndfc N + - - - non-disease-associated 
MB 1047 sepcemia relevant 16 - - - 1239 Sc 7-3 + - - - non-disease-associated 
SS 4339 pneumonia, colitis not relevant 16 - - - 1127 Sc N + - - - non-disease-associated 
PP 263 sepcemia relevant 16 - - - 1121 Sc 7-3 + - - - non-disease-associated 
MB 126 no gross lesions not relevant 16 - - - 1111 ndfc N + - - - non-disease-associated 
MB 1091 pneumonia, sepcemia relevant 16 - - - 1116 ndfc N + - - - non-disease-associated 




relevant 28 - - sly 1100 Sc N + - - - non-disease-associated 
SS 2739 pneumonia not relevant 28 - mrp* sly 1118 Sc N + - - - non-disease-associated 
PP 560 meningis relevant 31 - - - 1122 Sc N + - - + non-disease-associated 








relevant NTa - - - 1244 Sc ungroupabled + - - - non-disease-associated 
PP 216 sepcemia relevant NTa - - - 1120 Sc ungroupabled + - - - non-disease-associated 
PP 464 pneumonia not relevant NTa - - - 1108 Sc novel1e + - - - non-disease-associated 
PP 715 pneumonia, polyarthris not relevant NTa - - - 1123 Sc ungroupabled + - - - non-disease-associated 
PP 262 pneumonia, sepcemia not relevant NTa - - - ndb - ungroupabled + - - - non-disease-associated 
MB 810 pneumonia not relevant NTa - - - 1243 Sc ungroupabled + - - - non-disease-associated 
Isolates were chosen based on the fact of an unequivocal link of etiologically relevant S. suis diseased or non-disease-associated pigs. Pathotyping results, which did 
not correspond to the results obtained by histopathological findings, are indicated in red.* indicates two isolates, which were included in the evaluation although 
a record of histopathological findings was missing, but due to evident bacteriological findings and appropriate anamnesis, strains were evaluated as relevant. mrp 
variants identified: mrpS (747 bp), mpr (1148 bp), mrp* (1556 bp), mrp*** (2400 bp). epf* represents a large variant of epf, which was detected only in one isolate (19-
1715-1). +* relates to the pathotyping tool representing a variant PCR product of copper exporting ATPase gene.
a Nontypeable.
b Not determined (nd): one lacking housekeeping gene.
c No clonal complex could be assigned for ST that occurred as singletons (S) or with no determined founder (ndf ).
d Ungroupable: allele missing.
e Novel: allel combination not described for MCG sequencing typing by Zheng et al. [42].
f Wileman et al. [31].
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distribution of S. suis isolates in relation to ST revealed 
ST1104 (cps6, n = 13/13) with the highest prevalence of 
14.8% and no association to any CCs. Further on, 9.1% of 
isolates representing ST1105 (cps9, n = 8/14) were found 
to be unrelated singleton-isolates not associated to any 
CCs.
A total of 6.8% of isolates belonged to CC13/149 har-
boring ST13 (cps1, n = 6/6). 3.4% of isolates belonged 
to CC28 comprising ST29 (cps7, n = 3/4). ST17, ST28, 
ST231, ST1103, and ST1236 represented each 3.4% of 
isolates associated with CC17, CC28, CC1109, CC1, 
and CC1237, respectively. Finally, all remaining isolates 
had different STs only occurring in few isolates illus-
trating a massive genetic diversity identified in diseased 
Swiss pigs (Additional file  3). Samples comprising CC1 
included ST1103 (cps2, n = 3/4). ST17 (cps4, n = 3/3) 
was part of CC17. The most abundantly identified CC28 
contained isolates of ST28 (cps1/2, n = 2/3; cps2, n = 1/4), 
ST29 (cps7, n = 3/4), ST856 (cps3, n = 1/4), and ST1133 
(cps1/2, n = 1/3). CC87 contained ST87 (cps8, n = 1/3) 
and ST1130 (cps7, n = 1/4). All isolates of ST13 (cps1, 
n = 6/6) were part of CC13/149. CC1109 comprised iso-
lates of ST231 (cps3, n = 2/4; cps9, n = 1/14), ST1106 
(cps8, n = 1/3), ST1109 (cps8, n = 1/3; cps9, n = 1/14), and 
ST1113 (cps3, n = 1/4). CC1112 harbored only one isolate 
of ST1112 (cps15, n = 1/6). Finally, CC1237 comprised 
ST1236 (cps9, n = 3/14), ST1237 (cps9, n = 1/14) and 
ST1240 (cps21, n = 1/2) (Table 3).
Virulence profiling
CC1 harbored one cps2 isolate with a large variant of 
epf* (mrp+epf*sly+), whereas two cps2 isolates had 
a mrp+epf−sly+ genotype. Variable subtypes of mrp 
were identified in one cps2 isolate and two cps1/2 iso-
lates with a genotype of mrpSepf−sly−; one cps1/2 iso-
late, one cps3 isolate, and three cps7 isolates contained 
mrp***epf−sly−. Furthermore, genotype mrpSepf+sly+ 
was found in all three isolates of cps4 belonging to 
CC17. Two isolates of cps15 had a mrp***epf+sly+ 
genotype, whereas one isolate of each cps15 and cps28 
contained mrp*epf−sly+. 22.7% of isolates showed 
a mrp−epf−sly+ genotype, which was associated 
with CC13/149 consisting of cps1 (n = 6/6); CC1109 
comprising cps3 (n = 3/4), cps8 (n = 2/3), and cps9 
(n = 2/14); CC87 consisting of cps7 (n = 1/4), and cps8 
(n = 1/3); CC1237 comprising cps9 (n = 1/14); and ulti-
mately, singleton-isolates consisting of cps15 (n = 3/6) 
and cps28 (n = 1/2). Finally, a total of 56.8% of isolates 
studied had a mrp−epf−sly− genotype, which could not 
be associated to any CCs and were identified as sin-
gletons consisting of cps5 (n = 2/2), cps6 (n = 13/13), 
cps9 (n = 11/14), cps12 (n = 3/3), cps16 (n = 6/6), cps19 
(n = 1/1), cps21 (n = 2/2), cps31 (n = 3/3), and NT 
(n = 9/9) (Additional file 2).
MCG typing
MCG typing revealed MCG group 1 for members of 
CC1, CC17, and CC1112; MCG group 2 for isolates of 
CC87; MCG group 4 for isolates of CC28; MCG group 
N (representing an ungroupable subset of isolates) for 
CC13/149 and CC1109; and a novel MCG group for iso-
lates of CC1237. In total, 13.6% of isolates were classified 
into five novel MCG groups not previously described 
(Table  4). Almost 30% of isolates could not be assigned 
to any MCG group due to the failure of one housekeeping 
gene identification.
Pathotyping for differentiation between invasive 
disease‑associated and non‑disease‑associated isolates
Figure  4 shows the amplicon patterns obtained by 
multiplex PCR after capillary electrophoresis. Ampli-
cons of S. suis specific genetic marker (SSU0577) were 
obtained by all isolates proving the correct species 
identification. Amplicons of 892  bp represented the 
putative sugar ABC reporter as a non-disease-associ-
ated marker (SSUT30534), whereas disease-associated 
gene markers were identified by amplicons of 347  bp 
and 211  bp illustrating a type I RM system S protein 
(SSU1589) and a predicted copper ATPase (SSU0207), 
respectively. Additionally, new variant forms of the 
copper ATPase gene marker appeared, illustrated by 
a 190  bp long amplicon (Additional file  4). In total, 
29.3% (n = 22/75) of isolates analyzed harbored a 
gene variant of the copper ATPase gene containing 
partial deletions, represented by all isolates of CC28 
(n = 7/75), CC1109 (n = 7/75), and cps9 isolates with 
ST1105 (n = 8/75). As a contrast, 4% (n = 3/75) of iso-
lates belonging to CC1 showed a 211 bp long amplicon 
as comprehended by the virulent P1/7 strain (Table 2). 
The disease-associated marker type I RM system S 
protein-gene revealed a PCR amplification of 347  bp 
only for the three isolates comprising CC1. Sequence 
analysis of some exemplary isolates with cps1/2, cps1, 
and cps2 revealed a truncated gene version of the 
implicated gene, whereas the reverse primer could not 
bind to the target sequence due to the absence of the 
3′end of the gene in most isolates analyzed (Additional 
file 4).
Pathotyping of the subset of 75 isolates unequivo-
cally attributed as S. suis relevant or not S. suis relevant, 
revealed isolates of cps2 and cps9 to be in accordance 
with the pathotyping tool. However, comparing S. suis 
relevant isolates of cps1 and cps6 to results obtained by 
pathotyping, all isolates yielded a contradictory result. 
All other cps types could not clearly be classified by 
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pathotyping due to the paucity of isolates having the 
same capsular type and therefore no statement can be 
made.
Discussion
In this study a detailed assessment of genetic charac-
teristics of Swiss S. suis isolates of diseased pigs was 
performed and compared to an earlier analyzed human 
isolate. In general, seventeen different cps types were 
identified underlining high serotype diversity in accord-
ance to a previously observed massive diversity in whole 
genome sequences of a chosen set of isolates of clinically 
affected pigs [43]. The most common cps types found 
among the examined strain collection were cps9 and 
cps6. Contrary to a German investigation with over 700 S. 
suis isolates, not a single cps6 strain was found, which is 
worth to highlight when keeping in mind that Germany 
is a main neighboring country of Switzerland [44].
In the current report, all 13 isolates identified as cps6 
comprised a single clone of ST1104, which was not asso-
ciated to any CCs. ST1104 is representing a clone with 
no determined founder, identified to be a single locus 
variant (SLV; differing only at cpn60) of a Danish invasive 
S. suis strain with ST55 [45]. Noteworthy, this identified 
clone reoccurred throughout eight different years (Fig-
ure 2) underlining its capacity of causing disease in pigs 
due to an invasive behavior of the involved strain. Inter-
estingly, a study from Chile, investigating phenotypically 
and genotypically diseased pigs at nonrelated farms dur-
ing the time span of 2007–2011, revealed a single clone of 
S. suis with n = 28/29 of isolates identified to be serotype 
6. Although an invasive phenotype could be observed, 
no enhanced virulence could be proven in a murine 
model testing serotype 6 isolates from Chile including 
the Danish serotype 6 reference strain. No concomitant 
infections of the involved isolates could be observed, 
therefore, an enhanced virulence capacity was suggested 
[46].
Furthermore, it was notable that all isolates belonging 
to cps9 were rather heterogenic harboring five differ-
ent STs, although one abundant ST (ST1105, n = 8/14) 
seemed to be predominant among the identified samples. 
The genetic diversity of cps9 isolates in China and Can-
ada showed a high variety among examined isolates [47, 
Figure 1 Sequence type (ST) distribution of porcine S. suis in relation to capsular type. Identified STs are shown in form of a stacked 
histogram and illustrated in the corresponding bar sections. Nontypeable (NT) isolates could not be identified by multiplex PCR. Isolates with one 
lacking housekeeping gene identification could not be determined (nd).
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48], which is comparable to the observed genetic diver-
sity of inspected Swiss isolates. Interestingly, the afore-
mentioned clone comprising ST1105 reoccurred within 
six different years (Figure 2) emphasizing its importance 
among the pig population in Switzerland and its ability 
to induce infections. Similar reports of pigs with invasive 
disease have stated a predominance of mrp*cps9 belong-
ing to CC16/CC87 for Europe including The Netherlands, 
Spain, Germany and Belgium [9, 16]. The observation 
that cps9 isolates of the present study did not harbor mrp 
together with the identification of novel sequence types, 
underlines the emergence of very unique S. suis strains 
with new genetic rearrangements rarely found in other 
countries.
Actually, Switzerland has very little traffic of piglets 
with foreign countries and the pig farming system is dif-
ferent in comparison to other European countries. Herds 
are much smaller and the utilization of farrowing crates 
for reproduction purposes is prohibited by law since 
1997. The physiological behavior in nesting is impaired 
due to the narrowing conditions in farrowing crates and 
consequently, a more natural environment helps to avoid 
complications during birth of piglets thereby strengthen-
ing their immune status. In addition, Switzerland is con-
sidered to be free of porcine reproductive and respiratory 
syndrome virus (PRRSV) [49] and Mycoplasma hyopneu-
moniae [50]. Moreover, a majority of farms vaccinate pig-
lets against porcine circovirus (PCV) [51]. The general 
health status of Swiss pigs is considered to be high, which 
could be explained by the absence of these pathogens 
considered to be immunosuppressive and therefore hav-
ing an implication in the defense of S. suis. Nevertheless, 
stress caused by weaning at an age of 28 days and rehous-
ing of piglets usually after 10–12 weeks frequently paired 
Figure 2 MLST‑based minimal spanning tree of 88 porcine S. suis isolates. The MLST-based minimum spanning tree is representing the 
temporal distribution of sequence types determined for S. suis isolates collected during the last 13 years from diseased pigs. The tree was calculated 
using the goeBURST full MST algorithm in Phyloviz 2.0. Sizes of nodes reflect the number of isolates with a specific MLST profile. Numbers within the 
nodes indicate the corresponding sequence type. Node colors refer to the year of isolation as represented in the legend. Numbers on lines indicate 
locus variants between nodes. Black lines indicate single locus variants and grey lines represent multi locus variants. x and y represent isolates with 
no determined ST due to lacking of housekeeping gene identification.
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with a change of feed at the fattening farms can lead to 
infection caused by virulent S. suis strains. Fattening 
farms usually combine weaning piglets of different farms 
leading to a higher transmission rate of S. suis among pig-
lets. These circumstances could explain the high genetic 
variability and the distinct composition regarding ST and 
capsular types of S. suis strains obtained in this study in 
contrast to other countries.
Most remarkably, isolates belonging to CC1 are 
considered as potentially zoonotic and were mostly 
described as virulent strains [26]. In the present study 
three out of four isolates comprising cps2 were identi-
fied belonging to CC1. Showing its current relevance, 
one cps2 isolate originating from a brain of a diseased 
pig, was collected very recently in fall 2019, highlight-
ing an emerging S. suis clone with ST1103. Interest-
ingly, the implicated strain had a mrp+epf*sly+cps2 
genotype containing a large variant of epf, which is 
considered to be a moderately virulent pathotype [21]. 
In fact, this specific clone is a SLV of ST1, differing only 
in allele gki. The fourth cps2 isolate had a more com-
mon ST28 belonging to CC28. One highly virulent 
human ST1 (cps14) isolate from another study [52] was 
also part of CC1 harboring mrp+epf+sly+ underlining 
an association between virulence-associated markers 
epf, mrp, and sly with STs rather than cps types (Fig-
ure  3). Three cps2 isolates (ST1103) were classified as 
MCG group 1, whereas the fourth cps2 isolate (ST28) 
was part of MCG4. For the human isolate, MCG typ-
ing revealed a novel group not described before, which 
was uniquely attributed to this isolate. The fact that 
this isolate was classified as a novel MCG group, absent 
among the analyzed Swiss porcine isolates, proves an 
improbable transmission event of this highly virulent 
pathogenic isolate from Swiss pigs pointing out a dif-
ferent source of infection. The fact that the virulent 
Figure 3 Population snapshot of S. suis in Switzerland. Groups at triple locus variants (TLV) level were created by goeBURST v1.2 software 
using the phyloviz software [41] applying a data set from the PubMLST database (https ://pubml st.org/ssuis ). Grey lines define a link at double locus 
variant (DLV) or triple locus variant (TLV) between the CCs following eBURST rules. Numbers in nodes represent sequence types (ST), whereas light 
green represents founder groups, blue shows common nodes and red indicates STs identified in Switzerland. Clonal complexes (CCs) identified are 
indicated in bold. Association of Swiss isolates between capsular types (cps), ST and its corresponding CCs is shown. Identified virulence markers 
namely extracellular protein factor (epf), muramidase-released protein (mrp), and suilysin (sly) are indicated, highlighting its correlation with 
according STs and CCs. Isolates harboring mrp + epf + sly + , mrp + (epf +)sly + , sly + , and mrp + are represented in pink, green, orange, and brown, 
respectively. Variants of mrp are indicated with mrpS (small variant) and mrp*** (large variant); variant of epf is marked as epf* (large variant). Isolates 
appearing as singletons or with no determined founder are not represented. CC1109 and CC1237 are shown separately with no connections to the 



























Table 3 S. suis clonal complexes (CCs) in relation to capsular type and the according sequence types (ST). 
a No CCs assigned for STs observed as singletons or with no determined founder.
b Nontypeable by multiplex PCR.
c ST could not be assigned due to failure of one housekeeping gene identification.
d Novel STs.
Clonal complex (CC) Caspular type Sequence Types (STs)
1/2 1 2 3 4 5 6 7 8 9 12 15 16 19 21 28 31 NTb
CC1 3 1103d
CC17 3 17,  1112d
CC28 3 1 1 3 28, 29, 856,  1133d
CC87 1 1 87,  1130d
CC13/149 6 13
CC1109 3 2 2 231,  1106d,  1109d,  1113d
CC1112 1 1112d
CC1237 4 1 1236d,  1237d,  1240d
no  CCa 2 13 8 2 5 6 1 1 2 3 8 1099-1102d,  1104d,  1105d,  1107d,  1108d,  1110d,  1111d, 1114-
1116d,  1116d, 1117-1129d,  1134d,  1238d,  1239d,  1243d, 
 1244d
Ungroupablec 1 1 –
Total no. of isolates (n) 3 6 4 4 3 2 13 4 3 14 3 6 6 1 2 2 3 9
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strain was introduced through a person originating 
from Moldova importing meat to Switzerland [52], 
proves an independent introduction of this zoonotic 
strain. Furthermore, all cps4 isolates which are part of 
CC17 were classified as MCG group 1 with a genotype 
of mrpSepf+sly+ emphasizing a possible increased viru-
lence potential. In addition, a majority of cps15 isolates 
belonged to MCG group 1, whereas two isolates had 
a mrp***epf+sly+ genotype. Moreover, most isolates of 
cps7 were ST29 and belonged to CC28, similar to an 
emerging virulent strain recently reported in Germany 
[53] highlighting that isolates classified to be part of 
CC28 clearly show invasive and highly virulent features.
To evaluate the usefulness of pathotyping [31], a sub-
set of 75 isolates having an unequivocal link of etiologi-
cally relevant S. suis diseased or non-disease-associated 
pigs was screened by the pathotyping tool. Cps2 and cps9 
showed a clear correlation between pathotyping results 
and histopathological findings. Remarkably, compar-
ing observed phenotypes classified to be S. suis relevant, 
obtained by a combination of histopathological exami-
nations and bacteriological analysis, to results obtained 
by pathotyping, isolates of cps1 and cps6 yielded a con-
tradictory result since no gene marker indicating dis-
ease-association yielded a positive PCR result. Due to 
the perceived inconsistency of phenotypically observed 
manifestations determined to be S. suis relevant in con-
trast to the non-S. suis relevant results obtained with 
the pathotyping tool, sequence analysis of the involved 
gene markers (type I RM systems S protein- and copper 
ATPase-gene) was performed highlighting a high genetic 
variability of different isolates (Additional file 4). Worth 
mentioning, all cps type 1 isolates (ST13) were associated 
to CC13/149. Interestingly, in two previous studies [29, 
54] isolates of ST13 were associated with a pathogenic 
phenotype and represented an indicator of virulence 
underlining its importance. Yet undiscovered poten-
tial virulence factors especially of cps1 and cps6 strains 
remain matter of further investigation.
Cps3, cps7, cps15, and cps16 showed partially contra-
dictory results between histopathological findings and 
the pathotyping tool, which points out the difficulty of 
consistent histopathological examinations, considering 
the multifaceted properties of bacterial infections.
Conclusion
With this study an expanded knowledge about the popu-
lation structure and the genetic diversity of S. suis could 
be achieved. The epidemiological situation of S. suis in 
Switzerland revealed a heterogeneous composition of 
strains with high genetic variability belonging to several 
CCs. Strikingly, cps9 and cps6 were among the predomi-
nant capsular types associated with S. suis diseased pigs. 
Genetic variant forms of implicated disease-associated 
genes can be explained partially with frequent genomic 
rearrangements in S. suis as shown previously [27, 55]. 























Nc novel1d novel2e novel3f novel4g novel5h
2028696 A G G G G G G G G G G G G G G G 
2028744 A A G G G G G G G G G G A A G G 
824818 T T C T T T T T T T T T T T C T 
822644 C C C T C C C C C C C C C C C C 
107453 A A A A G A A A A A A A A G A A 
825000 G G G G G A G G G G G G G G G G 
81999 G G G G G G T G G G G T G G G G 
81404 A A A A A A A G A A A A G A A A 
81419 T T T T T T T T G T T T T T T G 
572576 G G G G G G G G G A G A G G A A 
MCG groups as defined by Zheng et al. [42] including 5 novel MCG groups identified in the present study. Red highlights discriminative SNPs for each SNP profile.
a Reference genome: strain GZ1 (GenBank accession number: CP000837).
b Epidemic (E) strains (ST7 strains) identified by Zheng et al. [42].
c Ungroupable.
The following isolates resulted in novel MCG groups with a new SNP profile.
d MB1158 (cps type 5), MB1497, SS2097 (cps type 9), PP106 (cps type 19), MB1185 (cps type 21), SS921 (nontypeable).
e MB1629 (cps type 12).
f Human pathogen strain (cps type 14).
g MB 1297 (cps type 31).
h SS 3919 (cps type 31).
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These genetically variable and distinct rearrangements 
could be facilitated by the unique pig farming of Switzer-
land with very little transfer of piglets from other Euro-
pean countries, however, with a frequent transport rate 
of weaning piglets to fattening farms.
In view of an affordable tool as a diagnostic application 
to rapidly discover highly invasive S. suis strains and to 
highlight a potentially threatening zoonotic pathogen, 
it would be advantageous to have a reliable pathotyping 
tool. The screening using our well characterized strain 
collection showed a good feasibility of the tool for cps2 
Figure 4 Capillary electrophoresis plots illustrating invasive disease‑associated and non‑disease‑associated Swiss S. suis isolates. 
On the left hand side the DNA size marker (100 bp–2.5 kb) is shown. The alignment marker (green) is representing the start and end of 
electrophoresis. Amplicons sizes obtained from the molecular pathotyping tool [31] are indicated on the right hand side. Lane 1 corresponds to 
the amplification reaction of a highly virulent isolate of cps type 2 (sequence type 1103) revealing both disease-associated markers (red) predicting 
a putative copper exporting ATPase 1 (SSU0207) and a type I restriction-modification (RM) system S protein (SSU1589). Lane 2 and 3 represent 
disease-associated isolates harboring the copper ATPase and a variant form with a 21 base pair (bp) deletion (lane 3), respectively. Lane 4, 5, and 
6 demonstrate observed amplification patterns of non-disease-associated samples (blue). Lane 4 shows a PCR amplicon for the putative sugar 
ABC reporter (SSUST30534) also in the presence of the copper ATPase gene. Samples with no amplification of any markers are considered to be 
non-disease-associated (lane 5). A sporulation regulator (WhiA) serves as identification control for S. suis (SSU0577).
Page 14 of 16Scherrer et al. Vet Res           (2020) 51:85 
and cps9, however, for cps1 and cps6 contradictory results 
were obtained. Therefore, we recommend using the 
pathotyping tool only in case of cps2- and cps9-identifi-
cation in order to differentiate between invasive disease-
associated isolates and non-disease-associated isolates.
An efficient identification of highly virulent strains 
could help to alert public health surveillance programs 
to take action in line with a one health approach. Keep-
ing track of disease-associated isolates helps to reduce 
the risk of zoonotic infections and will allow promoting a 
high standard in animal welfare programs.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1356 7-020-00813 -w.
Additional file 1. Capsular type distribution among Swiss S. suis 
isolates. Number of isolates in relation to capsular type is indicated. 
NT = nontypeable due to no successful capsular typing by multiplex PCR. 
Additional file 2. Clinical data, genotyping, and determination of 
virulence markers of Swiss porcine S. suis isolates (n = 88). 
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sequence type and clonal complex. 
Additional file 4. Alignment of target gene sequences and the cor‑
responding amino acid sequences used by pathotyping. Sequence 
alignment of copper ATPase 1-gene (A and B) and partial gene sequence 
alignment of type I RM system S protein-gene (C and D) of invasive 
disease-associated isolates of Swiss S. suis in comparison to the highly 
virulent reference strain P1/7 are shown visualizing different gene variants 
and its corresponding protein sequences. Conserved, matching nucleo-
tide residues are illustrated as blue dots, whereas red represents differ-
ences of nucleotide sequences. (A) Copper ATPase 1-gene sequences of S. 
suis PP463 (cps2, ST28), SS470 (cps1/2, ST28), PP423 (cps1/2, ST1133), and 
PP536 (cps9, ST1105) are represented. Primer sequences of the pathotyp-
ing tool are indicated in green. A duplication of a 54 bp long DNA seg-
ment in isolate SS470 and deletion of a 21 bp fragment in all represented 
Swiss isolates could be observed, illustrating a high genetic variability. 
(B) Corresponding amino acid sequence alignment of Copper ATPase 1 
is shown. (C) RM system S protein gene sequences of S. suis PP463 (cps2, 
ST28), PP423 (cps1/2, ST1133), and PP269 (cps1, ST13) are represented. The 
forward primer is indicated in green, whereas the reverse primer could not 
be shown since illustrated Swiss isolates are truncated. (D) Corresponding 
amino acid sequence alignment of RM systems S protein is shown.
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